CD4 and neoplasm: As shown in Figure 3, B–E, tumor-infiltrating CD39+γδ Tregs in RSCRC significantly inhibited both CD4+/CD8+ T cell proliferation, and as expected, their suppressive functions were stronger than those of LSCRC.